News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...
Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
3d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Kennedy Jr., a longtime anti-vaccine conspiracy theorist, will now require placebo testing for “all new vaccines.”“All new ...
As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results